- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05475639
Axillary Phonophoresis Versus Post Isometric Facilitation in the Treatment of Shoulder Adhesive Capsulitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adhesive Capsulitis is a common cause of shoulder pain and disability and also a condition involving glen humeral pain and loss of motion. It is characterized by significant restriction of both active and passive motion that occurs in the absence of a known intrinsic shoulder disorder. The intervention strategies for AC include a trial of conservative therapy followed by more invasive procedures.it may be primary-onset is generally idiopathic or Secondary- results from known cause. Clinically, patients may present with pain and mild restriction of movement which can lead to a gross loss of function predisposing factor or surgical event . it is most frequent in women, diabetic population and patient older than 40 years .It is described as having 3 stages. Stage Ⅰ involves pain (freezing or painful stage) and lasts from 3 to 9 months and is characterized by an acute synovitis of the glen humeral joint. Stage Ⅱ (frozen or transitional stage) includes pain and restricted movement and lasts from 4 to 12 months. Stage Ⅲ (thawing stage) involves painless restriction and lasts from 12 to 42 months. Contributing factors include diabetes mellitus, stroke, thyroid disorder, dupuytren disease, complex regional pain syndrome and metabolic syndrome.
Axillary Phonophoresis and Post isometric facilitation play a major role in the treatment of adhesive capsulitis so this trial was conducted to determine which one has superiority. this trial has three groups. two experimental and one control group. pain ,function, pressure pain threshold will be measured.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient age will range from 30to 40years old from both sexes (male and female).
- All recruited subjects in the 2nd stage of adhesive capsulitis (transitional stage).
- The patient will be diagnosed and referred by orthopedist as Adhesive capsulitis.
- The diagnosis will be confirmed by shoulder MRI.
- The diagnosis will be confirmed by shrug test.
- The patient will be referred by anterior shoulder pain or anterolateral shoulder pain.
- Inclusion requirement include two or more of the following pain complaints: Grooming ones hair, Scratching your back and getting dressed, Overhead activities or Difficulty in the action of throwing the ball and giving a high -five.
- All patients will sign the informed consent before joining the study.
Exclusion Criteria:
- Previous fracture with or without internal fixation in the shoulder joint
- Any previous surgery in the shoulder joint and patient with tendon calcification
- Local corticosteroid injection to the affected shoulder within the last three months or recent ones (Michener et al, 2004).
- Neuromuscular disease
- Rotator cuff tear
- History of metastatic cancer or diagnosis of cancer within 12 months
- Unstable angina
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: axillary diclophenac phonophoresis ( diclophen gel "voltaren gel")
the subject in the axillary diclophenac phonophoresis group will receive axillary diclophenac phonophoresis using ultrasound 1 MHz to increases the absorbtion.
Diclofenac phonophoresis will be applied beside conventional therapy program ,Apply the diclophen gel (voltaren gel) on the head of the US in the axillary pouch of the capsule at 1.5 W\cm2 for 10 minutes as pulsed U.S. the group will be treated for 4weeks, 3 sessions per week and all patients will be assessed pre and post intervention.
|
axillary diclophenac phonophoresis (voltaren gel) will be received three times per week for four weeks
|
EXPERIMENTAL: Post isometric Facilitation Techniques.
the subject in the Post isometric Facilitation Techniques group will be treated by applying isometric contraction followed by isometric relaxation followed by stretching to the target muscle .when
performing isometric facilitation with the shoulder in flexion , the patient was seated with his\her back supported and the therapist standing facing the patient's painful shoulder .the
patient's shoulder joint was flexed to the maximum available range with the elbow completely flexed .the
patient performed isometric contraction of the shoulder extensors against maximum resistance provided by the therapist .this
contraction will last for 10 seconds followed by relaxation for 5 seconds .this
contraction will allow the shortened shoulder extensors to relax and permit easier stretching.the group will be treated for 4weeks, 3 sessions per week and all patients will be assessed pre and post intervention.
|
Post isometric facilitation exercise will be received three times per week for four weeks
|
ACTIVE_COMPARATOR: traditional physiotherapy (infrared, supervised exercise program, home exercise program)
The traditional physical therapy program, which includes Infrared (IR) lambs apply heat to deep joints such as shoulder joint. Avoid deltoid muscle; apply over thin, bony areas for maximum penetration. supervised exercise program are self-exercise included: 1-Codmans or pendulum exercise (circumduction): It should be done 5 times daily in 5 to 10 minute sessions Passive stretching exercise (for shoulder extensors, abductors, and internal rotator) home exercise program includes the same exercise as in supervised exercise program. The participant will instruct to perform exercises1-2 times/day within pain -free ROM. the group will be 4weeks, 3 sessions per week and all patients will be assessed pre and post intervention. |
Traditional physiotherapy will be received three times per week for four weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain intensity
Time Frame: up to six weeks
|
numerical rating scale (NRS) will be used for assessment of pain intensity.
the scale from 0 to 10 where 0 is no pain and 10 is the worst pain
|
up to six weeks
|
pressure pain threshold
Time Frame: up to six weeks
|
commander algometer will be used for measuring pressure pain threshold
|
up to six weeks
|
shoulder range of motion
Time Frame: up to six weeks
|
digital goniometer will be used for measuring range of motion
|
up to six weeks
|
shoulder functional activity
Time Frame: up to six months
|
Disability of the Arm, Shoulder, and Hand questionnaire (DASH) will be used for measuring shoulder function activity.
it is a shortened version of the DASH questionnaire that uses 11 items to measure the degree of difficulty in performing various physical activities due to a shoulder, arm, or hand problem (6 items); the severity of pain and tingling (2 items); and the problem's effect on social activities, work, and sleep (3 items)
|
up to six months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Bursitis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Diclofenac
Other Study ID Numbers
- P.T.REC/012/003719
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesive Capsulitis of Shoulder
-
Daniel G. RendeiroCompletedAdhesive Capsulitis of Shoulder | Frozen Shoulder | Shoulder Adhesive CapsulitisUnited States
-
Vanderbilt University Medical CenterOrthopedic Research and Education FoundationCompletedAdhesive Capsulitis | Frozen Shoulder | Adhesive Capsulitis of Unspecified ShoulderUnited States
-
University of VirginiaRecruitingAdhesive Capsulitis of Shoulder | Adhesive Capsulitis | Frozen ShoulderUnited States
-
University of MalayaNot yet recruitingAdhesive Capsulitis of Shoulder
-
Taipei Veterans General Hospital, TaiwanRecruitingAdhesive Capsulitis of ShoulderTaiwan
-
Health Education Research Foundation (HERF)RecruitingAdhesive Capsulitis of ShoulderPakistan
-
Taif UniversityCompletedAdhesive Capsulitis of ShoulderSaudi Arabia
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
-
Balikesir UniversityCompletedAdhesive Capsulitis of Shoulder
-
Ege UniversityCompletedAdhesive Capsulitis of Shoulder | Adhesive Capsulitis | Frozen Shoulder
Clinical Trials on Axillary Diclofenac phonophoresis
-
Prince Sattam Bin Abdulaziz UniversityCompletedSub Acromial Impingement SyndromeSaudi Arabia
-
Cukurova UniversityCompletedSubacromial Impingement SyndromeTurkey
-
University of JazanRecruiting
-
Ahlia UniversityCairo UniversityCompletedChronic Non-bacterial ProstatitisEgypt
-
University Hospital, LinkoepingRecruiting
-
Cairo UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7United States
-
University Hospital A CoruñaComplejo Hospitalario Universitario de Vigo; Complejo Hospitalario Universitario... and other collaboratorsRecruiting
-
KK Women's and Children's HospitalRecruitingBreast Cancer | Recurrent DiseaseSingapore